.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Healthtrust
US Army
Boehringer Ingelheim
Daiichi Sankyo
QuintilesIMS
UBS
Argus Health
Covington
Fuji

Generated: June 23, 2017

DrugPatentWatch Database Preview

Pilocarpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for pilocarpine and what is the scope of pilocarpine patent protection?

Pilocarpine
is the generic ingredient in six branded drugs marketed by Akorn, Lannett, Eisai Inc, Perrigo Pharma Intl, Impax Labs, Allied Pharma Inc, Novartis Pharms Corp, and Alcon, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for pilocarpine.

Summary for Generic Name: pilocarpine

Tradenames:6
Patents:1
Applicants:8
NDAs:9
Drug Master File Entries: see list12
Bulk Api Vendors: see list28
Clinical Trials: see list27
Patent Applications: see list9,908
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pilocarpine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
ISOPTO CARPINE
pilocarpine hydrochloride
SOLUTION;OPHTHALMIC200890-002Jun 22, 2010RXYesNo► Subscribe► Subscribe
Lannett
PILOCARPINE HYDROCHLORIDE
pilocarpine hydrochloride
TABLET;ORAL077220-002May 6, 2009ABRXNoNo► Subscribe► Subscribe
Novartis Pharms Corp
ISOPTO CARPINE
pilocarpine hydrochloride
SOLUTION;OPHTHALMIC200890-003Jun 22, 2010RXYesYes► Subscribe► Subscribe
Akorn
OCUSERT PILO-20
pilocarpine
INSERT, EXTENDED RELEASE;OPHTHALMIC017431-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Eisai Inc
SALAGEN
pilocarpine hydrochloride
TABLET;ORAL020237-002Apr 18, 2003ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Baxter
Farmers Insurance
Fuji
Moodys
AstraZeneca
QuintilesIMS
Cerilliant
Harvard Business School
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot